AU Patent

AU2011307087B2 — Substituted polycyclic carbamoyl pyridone derivative prodrug

Assigned to Shionogi and Co Ltd · Expires 2016-11-10 · 10y expired

What this patent protects

The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3‑hydroxy-4‑pyridone derivative prodrug having cap-dependent endonuclease inhibitory ac…

USPTO Abstract

The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3‑hydroxy-4‑pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011307087B2
Jurisdiction
AU
Classification
—
Expires
2016-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.